<DOC>
	<DOCNO>NCT00648362</DOCNO>
	<brief_summary>The objective study investigate bioequivalence Mylan 's glimepiride 1 mg tablet Aventis Amaryl® 1 mg tablet follow single , oral 1 mg ( 1 x 1 mg ) dose administer fasting condition .</brief_summary>
	<brief_title>Fasting Study Glimepiride Tablets 1 mg Amaryl® Tablets 1 mg</brief_title>
	<detailed_description />
	<mesh_term>Glimepiride</mesh_term>
	<criteria>1 . Age : 18 year old . 2 . Sex : Male and/or nonpregnant , nonlactating female . . Women childbearing potential must negative serum ( Beta HCG ) pregnancy test perform within 14 day prior start study even prior dose administration . If dose schedule Sunday Monday , HCG pregnancy test give within 48 hour prior dose study period . An additional serum ( Beta HCG ) pregnancy test perform upon completion study . b . Women childbearing potential must practice abstinence use acceptable form contraception throughout duration study . No hormonal contraceptive hormonal replacement therapy permit study . Acceptable form contraception include follow : 1 ) intrauterine device place least 3 month prior start study remain place study period , 2 ) barrier method contain use conjunction spermicidal agent , 3 ) surgical sterilization c. Women consider childbearing potential one follow report documented medical history : 1 ) postmenopausal absence menses least one ( 1 ) year , 2 ) bilateral oophorectomy without hysterectomy absence bleed least 6 month , 3 ) total hysterectomy d. During course study , study screen study exit include washout period , male woman childbearing potential must use spermicide contain barrier method contraception addition current contraceptive method . This advice document informed consent form . 3 . Weight : At least 60 kg ( 132 lb ) men 48 kg ( 106 lb ) woman subject within 15 % Ideal Body Weight ( IBW ) , reference Table `` Desirable Weights Adults '' Metropolitan Life Insurance Company , 1999 ( See Part II ADMINISTRATIVE ASPECTS OF BIOEQUIVALENCE PROTOCOLS ) . 4 . All subject judge normal healthy prestudy medical evaluation ( physical examination , laboratory evaluation , Hepatitis B Hepatitis C test , HIV test , 12lead ECG , urine drug screen include amphetamine , barbiturate , benzodiazepine , cannabinoid , cocaine , opiate screen , phencyclidine , methadone ) perform within 14 day initial dose study medication . 1 . Institutionalized subject use . 2 . Social Habits : . Use tobacco product within 1 year start study . b. Ingestion alcoholic , caffeine xanthinecontaining food beverage within 48 hour prior initial dose study medication . c. Ingestion vitamin herbal product within 7 day prior initial dose study medication . d. Any recent , significant change dietary exercise habit . e. A positive test drug include urine drug screen . f. History drug and/or alcohol abuse . 3 . Medications : . Use prescription and/or overthecounter ( OTC ) medication include limited aspirin , ibuprofen , NSAIDs within 14 day prior initial dose study medication . b.Use hormonal contraceptive hormone replacement therapy within 3 month prior study medication dosing . c.Use medication know alter hepatic enzyme activity within 28 day prior initial dose study medication . 4 . Diseases : . History significant cardiovascular , hepatic , renal , pulmonary , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic disease . b . Acute illness time either prestudy medical evaluation dosing . c. A positive HIV , hepatitis B , hepatitis C test . 5 . Abnormal clinically significant laboratory test result : a.Clinically significant deviation Guide Clinically Relevant Abnormalities ( See Part II ADMINISTRATIVE ASPECTS OF BIOEQUIVALENCE PROTOCOLS ) . b. Abnormal clinically relevant ECG tracing . 6 . Donation loss significant volume blood plasma ( &gt; 450 mL ) within 28 day prior initial dose study medication . 7 . Subjects receive investigational drug within 30 day prior initial dose study medication . 8 . Allergy hypersensitivity glimepiride drug sulfonylurea class . 9 . History difficulty swallow , gastrointestinal disease could affect drug absorption . 10 . Subjects serum creatinine level outside normal range .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>